{
  "meta": {
    "title": "Cervical_Cancer",
    "url": "https://brainandscalpel.vercel.app/cervical-cancer-b92fe868.html",
    "scrapedAt": "2025-11-29T18:30:48.386Z"
  },
  "questions": [
    {
      "id": 19018,
      "choices": [
        {
          "id": 76032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Clear cell </span></span></p>"
        },
        {
          "id": 76033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mucinous</span></span></p>"
        },
        {
          "id": 76034,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Serous</span></span></p>"
        },
        {
          "id": 76035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Transitional </span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common type of epithelial ovarian tumors are: </span></span></p>",
      "unique_key": "Q1503125",
      "question_audio": null,
      "question_video": null,
      "map_id": 31030,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: C. Serous</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">75-80% of epithelial cancers are serous histologic type</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Classification of ovarian tumors:&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image_v42aRtk.png\" style=\"height:311px; width:410px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">The commonest type of ovarian cancer is epithelial ovarian cancer, amongst which, serous type is most common</span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2547</strong></span></span></p>",
      "correct_choice_id": 76034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19027,
      "choices": [
        {
          "id": 76068,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bilateral mastectomy </span></span></p>"
        },
        {
          "id": 76069,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bilateral salpingo oophorectomy</span></span></p>"
        },
        {
          "id": 76070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">HPV vaccine</span></span></p>"
        },
        {
          "id": 76071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral contraceptive pill</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old unmarried girl, whose mother died of ovarian cancer comes to you for advice regarding prevention of ovarian cancer. Which of the following will you suggest her for prevention of ovarian cancer: </span></span></p>",
      "unique_key": "Q2334045",
      "question_audio": null,
      "question_video": null,
      "map_id": 31031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: D. Oral contraceptive pill</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">OCP is the only documented method of chemoprevention for prevention of ovarian cancer. </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><strong><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></strong></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A and B:</strong> Salpingooophorectomy and mastectomy are&nbsp;advisable after genetic testing in women with strong family history of ovariana and breast cancer. Also as she is unmarried, doing a salpingectomy now would not be a suitable surgery as she might want to concieve in the future.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong> HPV vaccine prevents cervical cancer. </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Risk Factors for epithelial ovarian cancer</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Nulliparity</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Early menarche, late menopause</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>White race</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Increasing age</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Family history</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Personal h/o breast cancer</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Ethnicity (European jews, Icelandic and Hungarian)</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Post menopausal HRT</strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>PID</strong></em></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:16px\">Protective Factors for Ovarian cancer</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong><span style=\"font-size:16px\">B/l salpingectomy or tubal ligation</span></strong></em></li>\r\n\t<li><span style=\"font-size:16px\"><strong><em>Oophorectomy</em></strong></span></li>\r\n\t<li><span style=\"font-size:16px\"><strong><em>Combined OCP</em></strong></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong>Pregnancy and breast feeding</strong></em></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: berek and noval 16 edition, page 2561</strong></span></span></p>",
      "correct_choice_id": 76071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19029,
      "choices": [
        {
          "id": 76076,
          "text": "<p><span style=\"font-size:12pt;\">Both BRCA1 and BRCA2 are associated with increased risk of ovarian cancer</span></p>"
        },
        {
          "id": 76077,
          "text": "<p><span style=\"font-size:12pt;\">Hereditary cancer tends to occur in women 10 years earlier than the non-hereditary ovarian cancers</span></p>"
        },
        {
          "id": 76078,
          "text": "<p><span style=\"font-size:12pt;\">Most BRCA related ovarian cancers are high grade mucinous cancers</span></p>"
        },
        {
          "id": 76079,
          "text": "<p><span style=\"font-size:12pt;\">Prophylactic salpingo oophorectomy reduces risk of BRCA related gynecological cancer by 95%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is FALSE regarding BRCA related hereditary ovarian cancer?</span></p>",
      "unique_key": "Q5605405",
      "question_audio": null,
      "question_video": null,
      "map_id": 31032,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Most BRCA related ovarian cancers are high grade mucinous cancers</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Most BRCA related ovarian cancers are high grade serous cancers</span></li><li><span style=\"font-size:16px;\">Offer risk reducing bilateral salpingooophoerctomy to patients with BRCA 1 mutation at 35-40 years and BRCA 2 mutation by 40-45 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:&nbsp;</strong>Both BRCA1 and BRCA2 are associated with increased risk of ovarian cancer</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The BRCA1 gene is located on chromosome 17q21.&nbsp;Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%).</span></li><li><span style=\"font-size:16px;\">BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%).</span></li><li><span style=\"font-size:16px;\">The&nbsp;estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 -&nbsp;74 percent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong>Hereditary cancer tends to occur in women 10 years earlier than the non-hereditary ovarian cancers. This is a correct statement</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong>&nbsp;Prophylactic salpingo oophorectomy reduces risk of BRCA related gynecological cancer by 95% and should be done once a woman who is BRCA positive, her family is complete.&nbsp;The only proven way to directly prevent ovarian cancer is surgical removal. In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>BRCA-Related Ovarian Cancer&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>BRCA genes (BRCA1 &amp; BRCA2)</strong> are tumor suppressor genes involved in <strong>DNA repair via homologous recombination</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Germline mutations</strong> in BRCA1 or BRCA2 increase the risk of <strong>high-grade serous epithelial ovarian cancer</strong> (HGSOC).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Diagnosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">All patients with epithelial ovarian cancer are advised to undergo <strong>genetic testing for BRCA mutations</strong>, regardless of age or family history.</span></li><li><span style=\"font-size:16px;\">Testing includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Germline BRCA1/2</span></li><li><span style=\"font-size:16px;\">Somatic BRCA testing (from tumor tissue)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Prognosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">BRCA-associated cancers have <strong>better initial response to platinum-based chemotherapy</strong>.</span></li><li><span style=\"font-size:16px;\">Improved <strong>progression-free survival</strong> and overall survival, especially with BRCA2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Targeted Therapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>PARP inhibitors</strong> (e.g., olaparib, niraparib):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Exploit synthetic lethality in BRCA-deficient cells</span></li><li><span style=\"font-size:16px;\">Used as <strong>maintenance therapy</strong> post-chemotherapy or in recurrent disease</span></li><li><span style=\"font-size:16px;\">Most effective in <strong>BRCA-mutated and homologous recombination deficient (HRD)</strong> tumors</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Prevention</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Risk-reducing salpingo-oophorectomy</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Recommended at 35–40 years (BRCA1) or 40–45 years (BRCA2)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">The BRCA genes increase the risk of serous epithelial ovarian cancers and breast cancers</span></li><li><span style=\"font-size:16px;\">BRCA1 gene is located on chromosome 17q21.&nbsp;Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%).</span></li><li><span style=\"font-size:16px;\">BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%).</span></li><li><span style=\"font-size:16px;\">The&nbsp;estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 -&nbsp;74 percent</span></li><li><span style=\"font-size:16px;\">The only proven way to directly prevent ovarian cancer is surgical removal.</span></li><li><span style=\"font-size:16px;\">In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Berek and Novak 16 edition, pg 2566, Page 738, Williams Gynecology 3rd edition</strong></span></p>",
      "correct_choice_id": 76078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19030,
      "choices": [
        {
          "id": 76080,
          "text": "<p><span style=\"font-size:12pt;\">Stage of the disease is I C3</span></p>"
        },
        {
          "id": 76081,
          "text": "<p><span style=\"font-size:12pt;\">The surgery is staging laparotomy with bilateral salpingectomy with omentectomy with pelvic and paraaortic lymphadenectomy</span></p>"
        },
        {
          "id": 76082,
          "text": "<p><span style=\"font-size:12pt;\">Post operative chemotherapy will be required</span></p>"
        },
        {
          "id": 76083,
          "text": "<p><span style=\"font-size:12pt;\">5-year Survival is around 70%</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old postmenopausal woman underwent staging laparotomy for ovarian malignancy. Intraoperatively, there was ascites present, 10*10 cm right ovarian cyst with an intact capsule, which ruptured during surgery to reveal solid areas, omentum had a 3*3cm deposit. The rest of abdominal organs were normal on palpation. On histopathology, ascites showed malignant cells, ovaries had serous carcinoma and the omentum showed malignant cells. Lymph nodes were free of tumor cells. Which of the following is TRUE for the patient?</span></p>",
      "unique_key": "Q4781988",
      "question_audio": null,
      "question_video": null,
      "map_id": 31033,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Post operative chemotherapy will be required</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As per the FIGO staging for ovarian carcinoma (which is a surgical staging), she has stage IIIc disease. </span><span style=\"background-color:transparent;font-size:12pt;\">as she has an abdominal deposit (omental deposit) of 3 cm</span></li><li><span style=\"font-size:12pt;\">lymph nodes are negative, there is no evidence of organ metastasis.</span></li><li><span style=\"font-size:12pt;\">The FIGO staging is shown below</span></li><li><span style=\"font-size:12pt;\">The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin&nbsp; + Paclitaxel)</span></li></ul><p>&nbsp;</p><p><strong>FIGO Staging of ovarian cancer</strong></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/ovarian-cancer-staging-figo.jpg\" alt=\"\" width=\"1000\" height=\"1103\"></p><p>&nbsp;</p><p><strong>Other Options:&nbsp;</strong></p><p>&nbsp;</p><p><strong>Option A:&nbsp;</strong><span style=\"font-size:12pt;\">Stage of the disease is I C3: The Stage is stage 3&nbsp;</span></p><p>&nbsp;</p><p><strong>Option B:</strong>&nbsp;<span style=\"font-size:12pt;\">The surgery for ovarian cancer is staging laparotomy with bilateral salpingectomy with omentectomy with pelvic and paraaortic lymphadenectomy: The surgery is staging laprotomy which includes Total abdominal hysterectomy with b/l salpingo-oophorectomy with pelvic and para-aortic LN dissection with omentectomy with optimal debulking of visible tumor tissue</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: </strong>5 year survival is 70%:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In ovarian&nbsp;cancer, 5-year survuval in Stage 1 is 90%, stage 2 is 70%, stage 3 is 40% and stage 4 is 20%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and</span></li><li><span style=\"font-size:12pt;\">ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin&nbsp; + Paclitaxel)</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Berek and novak 16 edition, 2577&nbsp;(page 2619)&nbsp;</strong></span></p>",
      "correct_choice_id": 76082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19031,
      "choices": [
        {
          "id": 76084,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bleomycin etopocide cisplatin (BEP)</span></span></p>"
        },
        {
          "id": 76085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel (CP)</span></span></p>"
        },
        {
          "id": 76086,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">EMACO</span></span></p>"
        },
        {
          "id": 76087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old female has epithelial ovarian tumor which on evaluation has been found to be unresectable and planned for neoadjuvant chemotherapy. Which of the following is the most suitable drug/drug combination for her?</span></span></p>",
      "unique_key": "Q7193836",
      "question_audio": null,
      "question_video": null,
      "map_id": 31034,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Carboplatin paclitaxel (CP)</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk. </span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer. </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">Other Options:</span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A:</strong> BEP protocol (Bleomycin, Etoposide, Paclitaxel) is the chemotherapy of choice in germ cell tumors</span></li>\r\n\t<li><strong>Option C:</strong> EMACO is the chemotherapy given in high risk choriocarcinoma</li>\r\n\t<li><strong>Option D:</strong> Methotrexate is recommended in low risk choriocarcinoma</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk. </span></span></li>\r\n\t<li><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\">Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer.</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek and novak 16 edition, 2600-02</strong></span></span></p>",
      "correct_choice_id": 76085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19037,
      "choices": [
        {
          "id": 76108,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She has clear cell epithelial ovarian tumor</span></span></p>"
        },
        {
          "id": 76109,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LDH is likely to be increased</span></span></p>"
        },
        {
          "id": 76110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She will require completion surgery with total abdominal hysterectomy and salpingooophorectomy </span></span></p>"
        },
        {
          "id": 76111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">These tumors are chemoresistant </span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old girl presents with adnexal mass and undergoes unilateral salpingooophorectomy. Histopathology shows large clear cells with abundant cytoplasm, large nuclei with fibrous septae containing lymphocytic infiltrate as shown. Which of the following statements is TRUE?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-753.jpg\" style=\"height:319px; width:400px\" /></span></span></p>",
      "unique_key": "Q6135192",
      "question_audio": null,
      "question_video": null,
      "map_id": 31035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. LDH is likely to be increased</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She has dysgerminoma and hence&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LDH which is the tumor marker is likely to be increased</span></span></p>\r\n\r\n<p><em><strong>Other Options:</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong>Option A:&nbsp;</strong></em>&nbsp;clear cell epithelial ovarian tumor: Clear cell tumors on microscopy have low cuboidal, polyhedral, <em><strong>hobnail</strong></em> or flattened cells with uniform nuclear atypia, prominent nucleoli and variable mitotic activity</span></span></li>\r\n\t<li><em><strong>Option B:&nbsp;</strong></em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">She will require completion surgery with total abdominal hysterectomy and salpingooophorectomy:&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fertility sparing surgery is preferred. If opposite side is suspicious, biopsy can be taken and chemotherapy is given.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:&nbsp;</strong>These tumors are radioresistant: These tumors are highly radiosensitive and chemosensitive. </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<p><em><strong>Dysgerminoma</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dysgerminoma is the commonest (30&ndash;40%) malignant germ cell tumor.</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">It arises from undifferentiated form of germ cells. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">In 5%: Dysgenetic gonads so karyotype may be required</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The counterpart of dysgerminoma in male is seminoma. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Majority (75%) of the tumors occur before the age of 30 years.</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Tumor marker is LDH</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Pathology: The shape is usually round or oval and is usually 5&ndash;15 cm in diameter; It is firm rubbery. It may be bilateral (10%). Cut section shows pink or yellow color. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Microscopic appearance: uniform large round cells,&nbsp;&nbsp;arranged in cords or clumps with abundant clear cytoplasm. Nuclei are large, irregular and hyperchromatic with varying degree of mitosis. There is intense infiltration of lymphocytes and plasma cells in the fibrous septum. Malignant in &gt; 50%</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Clinical features:&nbsp;&nbsp;not specific for the tumor. </span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Treatment:</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis&nbsp;In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done. </span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done. </span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The tumor is sensitive to both chemotherapy and radiotherapy.&nbsp;</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak, 16 ed, page 2624-33.</strong></span></span></p>",
      "correct_choice_id": 76109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19038,
      "choices": [
        {
          "id": 76112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor</span></span></p>"
        },
        {
          "id": 76113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Yolk sac tumor</span></span></p>"
        },
        {
          "id": 76114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dysgerminoma</span></span></p>"
        },
        {
          "id": 76115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dermoid tumor</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the tumor in which this HPE finding is likely?</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-754.jpg\" style=\"height:329px; width:400px\" /></span></span></p>",
      "unique_key": "Q8357959",
      "question_audio": null,
      "question_video": null,
      "map_id": 31036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Yolk sac tumor</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a HPE showing Schiller Duval body with central vessel and mantle of endoderm whish is typically seen in Yolk sac tumor</span></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Option A:</strong></em></span>&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor: Pathognomonic HPE image is Call Exner bodies. Coffee bean nuclei is also seen</span></span></li>\r\n\t<li><em><strong>Option B:</strong>&nbsp;</em><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dysgerminoma: Fried egg appearance is seen in HPE</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><em><strong>Option D:</strong></em> Dermoid: Cell lines of ectoderm, endoderm and mesoderm is seen</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ovarian Tumor Markers:&nbsp;</span></span></strong></em></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak, page 2640 </strong></span></span></p>",
      "correct_choice_id": 76113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19039,
      "choices": [
        {
          "id": 76116,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Schiller duval body</span></span></p>"
        },
        {
          "id": 76117,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Call exner body</span></span></p>"
        },
        {
          "id": 76118,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psammoma body</span></span></p>"
        },
        {
          "id": 76119,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Leydig cells</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the histopathological finding:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-755.jpg\" style=\"height:307px; width:400px\" /></span></span></p>",
      "unique_key": "Q4051319",
      "question_audio": null,
      "question_video": null,
      "map_id": 31037,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: B. Call exner bodies</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Call exner bodies are pathognomonic of granulosa cell tumors</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">They are a</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">rranged in small clusters or rosettes around central cavity, resembling a primordial follicle</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Other Options:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><strong>Option A: </strong>Schiller Duvall bodies are seen in yolk sac tumors and appear as shown</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217194937-1.jpeg\" style=\"height:195px; width:259px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option C:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psammoma body: These are seen in seous epithelial ovarian tumors and appear as shown:&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217195106-2.jpeg\" style=\"height:200px; width:252px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D: Leydig cells: Reinkes crystals are seen in sertoli leydig cell tumor</strong></li>\r\n</ul>\r\n\r\n<p><img alt=\"reinke's crystals - Leydig cell tumor | Womens health, Health, Tumor\" src=\"https://i.pinimg.com/originals/c9/6d/c6/c96dc66188b5b9a7f415b4a541503e09.png\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: Berek &amp; novak 16 ed, page 2648</strong></span></span></p>",
      "correct_choice_id": 76117,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19043,
      "choices": [
        {
          "id": 76132,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Granulosa cell tumor</span></span></p>"
        },
        {
          "id": 76133,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometriotic cyst</span></span></p>"
        },
        {
          "id": 76134,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dermoid</span></span></p>"
        },
        {
          "id": 76135,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Yolk sac tumor</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the tumor in the image:</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg\" style=\"height:400px; width:400px\" /></span></span></p>",
      "unique_key": "Q3711229",
      "question_audio": null,
      "question_video": null,
      "map_id": 31038,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans: C. Dermoid </strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>This is the typical gross image of an ovarian dermoid (mature cystic teratoma)</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>It is recognized by the typical hair, teeth and sebacious material</strong></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:&nbsp;</strong>Granulosa cell tumor: The gross appearance is as shown and features include:&nbsp;</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Well circumscribed, predominantly solid; occasionally solid and cystic</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lobulated, yellow-tan or tan-white cut surface</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201516-1.jpeg\" style=\"height:198px; width:254px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option B:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometriotic cyst: This typocally has chocolate like material as its content</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201807-2.jpeg\" style=\"height:194px; width:259px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D: </strong>Yolk sac tumor:&nbsp; Appear as&nbsp;<span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">solid gray-white with a gelatinous, myxoid, or mucoid appearance. Necrosis, cystic changes, and hemorrhage are often seen as shown</span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201941-3.jpeg\" style=\"height:195px; width:259px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>This is the typical gross pathological image of an ovarian dermoid</strong></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg\" style=\"height:400px; width:400px\" /></span></span></p>",
      "correct_choice_id": 76134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18984,
      "choices": [
        {
          "id": 75896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Diabetes</span></span></p>"
        },
        {
          "id": 75897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Multiparity</span></span></p>"
        },
        {
          "id": 75898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Obesity</span></span></p>"
        },
        {
          "id": 75899,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Tamoxifen therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old woman is diagnosed to have endometrial carcinoma on biopsy. She wishes to understand the high-risk factors for development of endometrial cancer. Which of the following is NOT a risk factor for development of endometrial carcinoma:</span></span></p>",
      "unique_key": "Q9829136",
      "question_audio": null,
      "question_video": null,
      "map_id": 31020,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Multiparity </span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture1_orutUsD.jpg\" style=\"height:647px; width:850px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unopposed Estrogen therapy is seen in scenarios like PCOS, estrogen secretinf tumors like granulosa cell tumor and HRT with only estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors for endometrial cancer include</span></span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early menarche and late menopause</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Obesity</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>DM</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Tamoxifen</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Atypical Endometrial hyperplasia</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Unopposed estrogen exposure&nbsp;</em></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>PCOS</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Granulosa cell ovarian tumor</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>HRT with only estrogen</em></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</em></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; Novak, 16 ed, page 2362</span></strong></span></span></p>",
      "correct_choice_id": 75897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18986,
      "choices": [
        {
          "id": 75904,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karman canulla</span></span></span></p>"
        },
        {
          "id": 75905,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual vacuum aspiration cannula</span></span></span></p>"
        },
        {
          "id": 75906,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pipelle endometrial aspiration cannula</span></span></span></p>"
        },
        {
          "id": 75907,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine sound </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the instrument given below:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture2.jpg\" style=\"height:273px; width:300px\" /></span></span></p>",
      "unique_key": "Q2240885",
      "question_audio": null,
      "question_video": null,
      "map_id": 31021,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Pipelle endometrial aspiration cannula</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This procedure is done in women with Abnormal Uterine Bleeding (AUB)</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The other ways to obtain an endometrial sample for HPE is by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroecopic guided endometrial biopsy (Gold standard)</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A: Karmans cannula:</strong> These are disposable plastic cannulas which are color coded dependng on their diameter and appear as shown below. They are used as aspiration cannulas which are attached to an manual vacuum aspirator and are used to aspirate products of conception.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Karman Cannula, Karman Cannula with Universal Adoptor, Karman Cannula  without Universal Adopter\" src=\"https://www.mediplusindia.com/wp-content/uploads/2017/10/mi1.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option B: Manual Vacuum Aspirator. </strong>This is attached to the Karman cannula and the vauum created is used in suction evacuation to aspirate products of conception</li>\r\n</ul>\r\n\r\n<p><img alt=\"White MVA Syringe, For Hospital And Laboratory\" src=\"https://5.imimg.com/data5/XU/RN/MY-2413456/mva-syringe.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option D: Uterine Sound: </strong>This is a slightly curved metal instrument used to measure the length of the uterine cavity in procedures like a D&amp;C or during insertion of an intra-uterine device</span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217215354-1.png\" style=\"height:192px; width:204px\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>An endometrial biopsy can be taken by</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Hysteroscopy guided endometrial biopsy (Gold standard)</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Dilatation and curettage</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><strong><em>Office endometrial aspiration in the OPD&nbsp;</em></strong></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref :&nbsp; </strong><a href=\"https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785</strong></a></span></span></p>",
      "correct_choice_id": 75906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18987,
      "choices": [
        {
          "id": 75908,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial aspiration cannula for endometrial sampling</span></span></span></p>"
        },
        {
          "id": 75909,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karman cannula for RPOC</span></span></span></p>"
        },
        {
          "id": 75910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual Vacuum aspiration for missed abortion</span></span></span></p>"
        },
        {
          "id": 75911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction evacuation for molar pregnancy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">What procedure is done with the given instrument:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture4.jpg\" style=\"height:258px; width:350px\" /></span></span></p>",
      "unique_key": "Q3879809",
      "question_audio": null,
      "question_video": null,
      "map_id": 31022,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Endometrial aspiration cannula for endometrial sampling</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg\" style=\"height:143px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</li>\r\n\t<li>It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</li>\r\n\t<li>This procedure is done in women with Abnormal Uterine Bleeding (AUB)</li>\r\n\t<li>The other ways to obtain an endometrial sample for HPE is by\r\n\t<ul>\r\n\t\t<li>Hysteroecopic guided endometrial biopsy (Gold standard)</li>\r\n\t\t<li>Dilatation and curettage</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Other Options</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong> Karman cannula for RPOC:&nbsp;</span></span></span>These are disposable plastic cannulas which are color coded dependng on their diameter and appear as shown below. They are used as aspiration cannulas which are attached to an manual vacuum aspirator and are used to aspirate products of conception.</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220652-1.jpeg\" style=\"height:212px; width:238px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option C:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual Vacuum aspiration for missed abortion. A Manual Vacuum Aspiratior (MVA)&nbsp;</span></span></span>&nbsp;is attached to the Karman cannula and the vauum created is used in suction evacuation to aspirate products of conception</li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220836-1.jpeg\" style=\"height:231px; width:218px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option D:&nbsp;</strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suction evacuation for molar pregnancy: Suction evacuation for molar pregnancy is usually done by a manual vacuum aspiration syringe as shown above or with an electrical vacuum aspiration in which the Karmans cannula is attached to an electrical suction machine</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg\" style=\"height:143px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li>This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</li>\r\n\t<li>It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</li>\r\n\t<li>This procedure is done in women with Abnormal Uterine Bleeding (AUB)</li>\r\n\t<li>The other ways to obtain an endometrial sample for HPE is by\r\n\t<ul>\r\n\t\t<li>Hysteroecopic guided endometrial biopsy (Gold standard)</li>\r\n\t\t<li>Dilatation and curettage</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref: </strong><a href=\"https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0</strong></a></span></span></p>",
      "correct_choice_id": 75908,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18989,
      "choices": [
        {
          "id": 75916,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial Carcinoma</span></span></span></p>"
        },
        {
          "id": 75917,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></p>"
        },
        {
          "id": 75918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
        },
        {
          "id": 75919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retained product of conception</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman visits OPD with heavy menstrual bleeding. Her USG is shown below Histopathology shows dilated cystic glands with increased gland: stroma ratio. The probable diagnosis is:</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture6.jpg\" style=\"height:231px; width:350px\" /></span></span></p>",
      "unique_key": "Q8846957",
      "question_audio": null,
      "question_video": null,
      "map_id": 31023,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial hyperplasia</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options</span></span></span></span></strong></em></p>\r\n\r\n<ol>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\">Option A: Endometrial cancer:</span></span></span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\"> In this the HPE will show features of carcinoma including&nbsp; c</span></span>ellular / nuclear enlargement, nuclear rounding with large nucleoli, loss of polarity and cytoplasmic eosinophilia</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option C: Molar Pregnancy: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">The USG image will show snowstorm appearance and the HPE will show, trophoblastic hyperplasia and villous edema</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option D: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Retained products of conception: This will appear as trophoblastic tissue on microscopy</span></span></li>\r\n</ol>\r\n\r\n<p><em><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek &amp; novak, 16 ed, page 2364</span></strong></span></span></p>",
      "correct_choice_id": 75917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18991,
      "choices": [
        {
          "id": 75924,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CA 125</span></span></span></p>"
        },
        {
          "id": 75925,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial aspiration biopsy</span></span></span></p>"
        },
        {
          "id": 75926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        },
        {
          "id": 75927,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prepare for hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">55-year-old post-menopausal woman presents to OPD with post-menopausal bleeding. Her USG shows endometrial thickness of 7mm. Next step in management is:</span></span></p>",
      "unique_key": "Q7713994",
      "question_audio": null,
      "question_video": null,
      "map_id": 31024,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial aspiration biopsy</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>\r\n\t<ul>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option A:</strong>&nbsp;CA 125: This is a marker for epithelial ovarian cancer</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option C:</strong> Pap smear: This is a screening test for cervical cancer. In the queston it is already mentioned that the endometrium is thickened so taking a pap smear will not be the net best step</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option D:</strong> Prepare for a hysterectomy: Am endometrial biopsy is required an only if there is endometrial hyperplasia with atypia or if ther eis endometrial carcinoma, should a hysterectomy be done</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: figo cancer report, 2021</span></strong></span></span></p>",
      "correct_choice_id": 75925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18994,
      "choices": [
        {
          "id": 75936,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be conserved</span></span></p>"
        },
        {
          "id": 75937,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be removed</span></span></p>"
        },
        {
          "id": 75938,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries can be removed if they appear pathological</span></span></p>"
        },
        {
          "id": 75939,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ovaries should be conserved if patient is pre-menopausal and should be removed if patient is post-menopausal </span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 49-year-old woman with biopsy proven endometrial cancer and MRI showing endometrial growth involving more than 50% myometrium is undergoing hysterectomy. What will be your advice regarding removal of ovaries?</span></span></p>",
      "unique_key": "Q3800665",
      "question_audio": null,
      "question_video": null,
      "map_id": 31025,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Ovaries should be removed</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient probably has an endometrial cancer which has infilterated into the myometrium</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">The recommended standard surgical procedure is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Adnexal removal is recommended even if the tubes and ovaries appear normal, as they may contain micrometastases. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">In premenopausal women with low-grade, early-stage disease, ovarian preservation could be considered</span></span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">&nbsp;</span></span></span></span></span></li>\r\n\t<li><em><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">Vaginal cuff removal is not advised, nor is there any benefit from excising parametrial tissue in the usual case.&nbsp;</span></span></span></span></span></em></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><strong><em>Educational Objective:&nbsp;</em></strong></span></p>\r\n\r\n<p><em><strong><span style=\"font-size:14px\">The recommended surgical procedure in endometrial cancer </span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy.</span></span></span></span></span></strong></em></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Figo cancer report 2021</span></strong></span></span></p>",
      "correct_choice_id": 75937,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18995,
      "choices": [
        {
          "id": 75940,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">The patient has stage IIIb disease </span></span></p>"
        },
        {
          "id": 75941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">No further treatment required as lymphadenectomy already done</span></span></p>"
        },
        {
          "id": 75942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Lymphadenectomy in endometrial cancer helps in staging and guiding further management </span></span></p>"
        },
        {
          "id": 75943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">The patient will require adjuvant vaginal brachytherappy</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman underwent hysterectomy with bilateral salpingooophorectomy with pelvic and para-aortic lymphadenectomy for endometrial cancer. Histopathology confirms lymph node involvement.&nbsp; Which of the following statements is correct: </span></span></p>",
      "unique_key": "Q1144376",
      "question_audio": null,
      "question_video": null,
      "map_id": 31026,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient has stage IIIc disease as per FIGO staging and&nbsp; she will require complete surgical resection (TAH + BSO with pelvic and para-aortic lymphadenectomy) followed by post operative adjuvant EBRT +/- chemotherapy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Lymphadenectomy is required for accurate staging and is considered a staging procedure. Its potential therapeutic benefits are mainly contribution to accurate indication for adjuvant therapy.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Most patients presenting with Stage&nbsp;III endometrial cancer are managed by complete surgical resection of all pelvic and/or nodal disease, followed by postoperative EBRT and/or chemotherapy.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">Other Options:&nbsp;</span></span></strong></em></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\"><strong>Option A:</strong>&nbsp;</span></span>The patient has stage IIIb disease: involvement of pelvic and para-aortic lymoh node involvement means stage III-C</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option B:&nbsp;</strong>No further treatment required as lymphadenectomy already done: Treatment of endocmtrial canncer is surgery f/b radiotherapy or chemotherapy. Only in very early stages with log grade tumor (Stage 1A1) is surgery sufficient</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option D:</strong>&nbsp;The patient will require adjuvant vaginal brachytherappy: Folowing surgery for endomatrial cancer, radiotherapy is given as external beam radiotherapy (EBRT) and not brachytherapy</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1c1d1e\">Educational Objective:&nbsp;</span></span></span></span></span></strong></em></p>\r\n\r\n<p><img alt=\"Image\" src=\"https://pbs.twimg.com/media/FzFlF3IWAAUU5Rn?format=jpg&amp;name=900x900\" /></p>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Figo cancer report 2021</span></span></span></strong></em></p>",
      "correct_choice_id": 75942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18996,
      "choices": [
        {
          "id": 75944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed estrogen</span></span></p>"
        },
        {
          "id": 75945,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed progesterone</span></span></p>"
        },
        {
          "id": 75946,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed estrogen</span></span></p>"
        },
        {
          "id": 75947,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed progesterone</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In relation to endometrial cancer which of the following is CORRECT:</span></span></p>",
      "unique_key": "Q1966014",
      "question_audio": null,
      "question_video": null,
      "map_id": 31027,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Type I endometrial cancer: due to unopposed estrogen</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial cancer is of 2 types: Type 1 (endometroid) and type 2 (non endometroid)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I endometrial cancers occur in women with history of exposure to unopposed estrogen. Type II endometrial carcinoma are estrogen independent tumors. </span></span></span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; novak, 16 edition, page 2362</span></strong></span></span></p>",
      "correct_choice_id": 75944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19000,
      "choices": [
        {
          "id": 75960,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometroid</span></span></p>"
        },
        {
          "id": 75961,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometroid with squamous differenciation</span></span></p>"
        },
        {
          "id": 75962,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mucinous</span></span></p>"
        },
        {
          "id": 75963,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Serous&nbsp; </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following type of endometrial cancer type has worst prognosis?</span></span></p>",
      "unique_key": "Q1014247",
      "question_audio": null,
      "question_video": null,
      "map_id": 31028,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Serous</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serous carcinomas are hgh risk lesions. They are a type of type 2 (non endometrioid) endometrial cancers and are more aggressive and have worese prognosis complared to type 1 cancers.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image.png\" style=\"height:281px; width:501px\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image_A9fgwQi.png\" style=\"height:281px; width:501px\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak, 16ed, page 2378</span></strong></span></span></p>",
      "correct_choice_id": 75963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19001,
      "choices": [
        {
          "id": 75964,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical and ovarian</span></span></p>"
        },
        {
          "id": 75965,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical and GTN</span></span></p>"
        },
        {
          "id": 75966,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometrial and cervical </span></span></p>"
        },
        {
          "id": 75967,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Endometrial and ovarian cancer</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common simultaneously occurring malignancies are:</span></span></p>",
      "unique_key": "Q6001566",
      "question_audio": null,
      "question_video": null,
      "map_id": 31029,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Endometrial and ovarian</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian granulosa cell tumors are frequenctly associated with endometrial hyperplasia and cancer due to unpoosed estrogen exposur</span></span></span>e</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek and novak, 16ed, page 2381</span></strong></span></span></p>",
      "correct_choice_id": 75967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}